tiprankstipranks
Advertisement

UDI - ETF AI Analysis

Compare

Top Page

UDI

USCF Dividend Income Fund (UDI)

Rating:73Outperform
Price Target:
UDI, the USCF Dividend Income Fund, has a solid overall rating that reflects a portfolio anchored by strong, cash-generative companies like Verizon, Medtronic, and Johnson & Johnson, which combine attractive dividends with positive growth and technical trends. Financially sound banks such as East West Bancorp and M&T Bank further support the fund’s quality, though holdings like AbbVie and Lamar Advertising introduce some risk due to leverage and valuation concerns. The main risk factor is that several key holdings are priced at a premium or face financial stability challenges, which could limit future upside if conditions worsen.
Positive Factors
Strong Recent Performance
The fund has delivered strong gains so far this year and in recent months, showing solid momentum.
Top Holdings Mostly Performing Well
Most of the largest positions, including major financial, energy, and health care companies, have shown strong or steady performance, supporting the ETF’s returns.
Sector Diversification
The ETF spreads its investments across many sectors such as financials, health care, energy, real estate, and utilities, which helps reduce the impact if one area of the market struggles.
Negative Factors
High Financial Sector Exposure
With a large share of assets in financial companies, the fund could be more sensitive to problems in banks and other financial institutions.
Mostly U.S.-Focused
The ETF invests heavily in U.S. stocks with only a small allocation to Canada, offering limited geographic diversification.
Above-Average Expense Ratio
The fund’s expense ratio is on the higher side for an ETF, which means more of the returns are used to cover fees.

UDI vs. SPDR S&P 500 ETF (SPY)

UDI Summary

The USCF Dividend Income Fund (UDI) is an ETF that invests mainly in U.S. companies across many sectors, with a focus on stocks that pay steady dividends rather than tracking a specific index. It holds well-known names like Johnson & Johnson and AbbVie, along with banks, energy firms, utilities, and real estate companies, giving investors broad diversification plus potential income. Someone might consider UDI if they want a mix of long-term growth and regular dividend payments. A key risk is that the fund is heavily invested in dividend-paying sectors like financials and energy, so its value can go up and down with those parts of the market.
How much will it cost me?The USCF Dividend Income Fund (Ticker: UDI) has an expense ratio of 0.65%, meaning you’ll pay $6.50 per year for every $1,000 invested. This is higher than average for ETFs because it is actively managed, focusing on carefully selecting dividend-paying stocks rather than tracking a broad index. Active management typically involves higher costs due to the research and decision-making required.
What would affect this ETF?The USCF Dividend Income Fund (UDI) could benefit from stable or declining interest rates, which often make dividend-paying stocks more attractive to investors, as well as continued growth in the healthcare and technology sectors, where it has significant exposure. However, rising interest rates or economic slowdowns could negatively impact the fund, particularly its financial and real estate holdings, which are sensitive to such conditions. Additionally, regulatory changes or sector-specific challenges in healthcare or financials could pose risks to its performance.

UDI Top 10 Holdings

UDI’s story is all about steady dividend powerhouses with a U.S. tilt. Energy names like Phillips 66 and ConocoPhillips are doing the heavy lifting, rising on strong cash flows and supportive earnings, while financials such as State Street and East West Bancorp add momentum from a healthier banking backdrop. Health care is a mixed bag: Johnson & Johnson looks steady, but Medtronic has been losing a bit of steam this year. Verizon and Paychex quietly support the fund, helping balance out softer spots without dominating the stage.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Johnson & Johnson3.69%$117.25K$663.28B54.25%
78
Outperform
Medtronic3.41%$108.20K$120.46B1.37%
80
Outperform
East West Bancorp3.38%$107.23K$17.92B21.56%
79
Outperform
AbbVie3.13%$99.51K$453.19B20.65%
66
Neutral
State Street3.09%$98.30K$53.36B71.99%
75
Outperform
Lamar Advertising3.00%$95.43K$15.31B17.78%
72
Outperform
Phillips 662.93%$93.11K$101.79B93.91%
73
Outperform
Verizon2.92%$92.71K$208.32B12.98%
81
Outperform
Conocophillips2.92%$92.64K$161.29B44.44%
78
Outperform
Canadian Natural2.86%$90.73KC$143.85B66.20%
81
Outperform

UDI Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
36.76
Positive
100DMA
35.64
Positive
200DMA
34.12
Positive
Market Momentum
MACD
0.19
Positive
RSI
58.00
Neutral
STOCH
77.96
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For UDI, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 37.34, equal to the 50-day MA of 36.76, and equal to the 200-day MA of 34.12, indicating a bullish trend. The MACD of 0.19 indicates Positive momentum. The RSI at 58.00 is Neutral, neither overbought nor oversold. The STOCH value of 77.96 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for UDI.

UDI Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$3.20M0.65%
73
Outperform
$99.04M0.89%
71
Outperform
$91.78M0.85%
68
Neutral
$90.82M0.59%
70
Outperform
$90.04M0.75%
70
Neutral
$88.84M0.65%
65
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
UDI
USCF Dividend Income Fund
37.48
7.35
24.39%
BAMD
Brookstone Dividend Stock ETF
STNC
Stance Equity ESG Large Cap Core ETF
PFOE
Pathfinder Focused Opportunities ETF
SOVF
Sovereign's Capital Flourish Fund
YALL
God Bless America ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement